Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the

Mary F Walter1, Robert F Jacob, Rebekah E Bjork

  • 1Elucida Research, Beverly, Massachusetts, USA.

Insights

Elevated lipid hydroperoxide (LOOH) levels predict adverse cardiovascular events in patients with stable coronary artery disease (CAD). This oxidative stress marker offers independent prognostic value beyond traditional risk factors.

Area of Science:

  • Cardiovascular Medicine
  • Biomarkers
  • Oxidative Stress

Background:

  • Oxidative modification of lipids contributes to atherosclerosis, inflammation, and endothelial dysfunction.
  • Lipid hydroperoxides (LOOH) are primary products of fatty acid peroxidation and serum biomarkers of oxidation.

Purpose of the Study:

  • To determine the predictive value of serum lipid hydroperoxide (LOOH) levels for adverse cardiovascular outcomes.
  • To assess LOOH as a prognostic marker in patients with stable coronary artery disease (CAD).

Main Methods:

  • Serum LOOH levels were measured in 634 patients with angiographic evidence of CAD.
  • Clinical events were tracked over a 3-year period.
  • Correlations with traditional risk factors and inflammatory markers were analyzed.

Main Results:

  • Higher baseline LOOH levels were significantly associated with increased risk of nonfatal vascular events, major vascular procedures, and overall vascular events.
  • LOOH levels correlated with markers of inflammation (soluble intercellular adhesion molecule-1) and lipid peroxidation (thiobarbituric acid reactive substances).
  • Multivariate analysis confirmed LOOH as an independent predictor of adverse cardiovascular outcomes, even after adjusting for traditional risk factors.

Conclusions:

  • Elevated LOOH levels are a significant independent predictor of nonfatal vascular events and procedures in patients with stable CAD.
  • LOOH serves as a valuable prognostic biomarker in cardiovascular risk assessment.
  • Amlodipine treatment showed potential in reducing cardiovascular events and modifying LOOH levels.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...